Galapagos NV
GLPG
#4961
Rank
โ‚ฌ1.60 B
Marketcap
23,96ย โ‚ฌ
Share price
0.00%
Change (1 day)
-3.72%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.60 Billion

As of June 2026 Galapagos NV has a market cap of โ‚ฌ1.60 Billion. This makes Galapagos NV the world's 4961th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.60 B-13.15%
2025โ‚ฌ1.85 B7.18%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ501.02 B 31,034.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ132.71 B 8,147.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ347.67 B 21,504.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ91.52 B 5,587.74%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ254.07 B 15,688.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ239.54 B 14,785.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ91.90 B 5,610.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ79.51 M-95.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.84 B 2,065.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel